pharmaceutical investing Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project